Speakers

SPEAKERS

Paola is the CEO of Alzheimer’s Disease International. Prior to that, she was CEO of LIFE. Her previous senior positions include Cass Business School, Tate, British Library and IIED.

She is a Non-Executive Director of the Non-Communicable Disease Alliance (NCDA) and a Trustee of The Postal Museum and Lauderdale House. Previously she was a Trustee of Shelter, the UK housing and homelessness charity and of MLA London.

She holds a degree cum laude in Classics from the University of Napoli Federico II, an MA in Field and Analytical Techniques in Archaeology and an MA in Library and Information Science both from University College London.

Chris Lynch is Deputy CEO at Alzheimer’s Disease International and Director of Policy, Communications & Publications.

Chris has over 25 years’ experience in communications, marketing, business development, policy, publications and events, working in the private, public and not for profit sectors.

On the director team at Alzheimer Scotland, Chris had responsibility for Communications, External Affairs, Marketing, Membership, Events, International liaison and Digital strategy, plus key fundraising activity.

With a passion for digital communication and transformation, he became a Scottish Government Digital Champion in 2016.

Chris has run his own marketing and business development consultancy, Future Marketing, as well as a successful hospitality business.

His pro-bono work includes start up and third sector business advice.

Shamil Mohamed is a retired hotelier and a registered client at the Lanka Alzheimer’s Foundation’s Activity Centre. He started experiencing difficulties in walking at age 54 and was subsequently diagnosed with fluid in the brain, which is a rare cause of dementia. He has been advocating for his country’s government to adopt a national plan for dementia that will enhance the quality of life for persons with dementia and their carers.

Professor Miia Kivipelto, MD, PhD is Deputy Head of KI-ARC and Professor in Clinical Geriatric Epidemiology at Karolinska Institutet in Stockholm. She is also Research Director of Neuroepidemiology unit at University of Eastern Finland. She is combining research with clinical medicine, working also as senior geriatrician at the Memory Clinic, Karolinska University Hospital. She has been working in several clinical trials concerning cognitive impairment and AD and is now Deputy Head of the Clinical Trials Unit.

Prof. Kivipelto is the principal investigator in the large population based Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study and in FINGER. Her research focus is the effects of and interactions between lifestyle-related and genetic factors on cognitive decline/dementia and prevention of AD and other aging-related diseases. Prof. Kivipelto has several PhD and post-doctoral students in her research group and she is involved in many international networks and scientific/steering committees. The unique combination as neuroepidemiologist and geriatrician gives a natural platform for the translational research proposed in the research plan.

Dr Christopher Chen Li-Hsian studied for the Medical and Natural Science Tripos at Fitzwilliam College, Cambridge University, and graduated with a Second Upper in Physiology & Psychology in 1982. His clinical training was at the University of Oxford where he obtained his BMBCh in 1985. He is currently an Associate Professor at the Department of Pharmacology and Director of the Memory Aging and Cognition Centre, National University Health System.

Since returning to Singapore in 1995, Dr Chen has developed a comprehensive multi-disciplinary dementia programme and encouraged collaborative research in the Asia-Pacific region and beyond. His current focus is on developing a regional network for innovative trials into conditions prevalent and pertinent to Asia. In addition, he has developed a Trials Unit focusing on stroke and dementia with wide international collaborations.

His major research and clinical interests are in neurochemistry, molecular biology and treatment of stroke and dementia. He has published over 250 peer-reviewed papers and book chapters, served on several editorial boards (Stroke, Journal of Neurology Neurosurgery and Psychiatry), trial steering committees and data safety monitoring boards. He is currently the Principal Investigator of the CHIMES trials, which has extensive international collaborations.

Dr Chen has also developed an international reputation for participation in academically driven as well as industry sponsored clinical trials. His aim is to develop synergies with basic neuroscience research and to translate novel scientific findings into therapeutic possibilities as well as to provide clinical insights for disease specific laboratory research.

Apart from international collaborative research programmes, Dr Chen works very closely with scientists from A*STAR and NUS. They have been studying biochemical and genetic markers underlying the pathophysiology of stroke. Longitudinal studies are also in progress to study the natural history, risk factors for and treatment to prevent cognitive impairment and dementia after stroke.

Dr Hamed is a senior Consultant Psychiatrist. He has a special interest in elderly mental health and Alzheimer’s disease. Dr Hamed did his post graduate training in the UK and completed his fellowship in Old Age Psychiatry. In 2011 he established the memory clinic at Sultan Qaboos University Hospital in Oman He is involved in several research projects in the area of mental health and he also delivers workshops and training related to mental health and medical education. He is Chairman of the Oman Alzheimer’s Society.

Michael Schmieder is a Swiss dementia pioneer. He is the former Director of Stiftung Sonnweid a care facility in Switzerland for people living with dementia, where he worked for thirty years. Sonnwied has become an international example of specialised dementia care. Prior to this he was an emergency services nurse He is an ethicist and an author. He is a member of the European Dementia Ethics Network, author of “Dementia, but not stupid” and an editor of the Journal Die Heft. He has developed the website alzheimer.ch as an information platform.

In 2017, Michael Schmieder was honored by the Paradies Foundation for his life’s work and he was awarded the Focus Prize in 2018 by the Alzheimer’s association in Zurich, Switzerland.

Dr Okech is a Consultant Psychiatrist and Counsellor at Kenyatta National Hospital (KNH) in Kenya. She is also an Honorary Lecturer at the University of Nairobi and Chair of the KNH Adult Psychiatry Services. She previously coordinated training, research, advocacy and outreach work at the KNH gender-based violence recovery centre.

Additionally, she has represented Kenya internationally in mental health care advocacy and in the professional development of early career psychiatrists on the global World Psychiatric Association Young Psychiatrics Council (WPA-YPC). This has led her to establish the Eastern Africa Association of Young Psychiatrist and Trainees (EAYPT).

Her volunteer public mental health service earned her a Fulbright scholarship to the prestigious Johns Hopkins Bloomberg School of Public Health in the US, where she earned a fellowship in Public Mental Health and Policy. She also graduated in 2013 with a Master’s in Public Health from the same University.

Martin Knapp is Professor of Social Policy and Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE). He has also been Director of the NIHR School for Social Care Research since 2009.

Professor Knapp has been working for many years in the fields of long-term care, social care, and mental health policy and practice. His current research emphases are primarily dementia, child and adult mental health, autism and long-term social care. Much of his work has an economic focus, and in all of it he seeks to tease out the policy and practice implications. He has published almost 600 peer-review journal papers and 15 books. His work has had numerous impacts on policy and practice in these areas.

A/Prof. Lim is Senior Consultant at Department of Geriatric Medicine and research track lead at the Institute of Geriatrics and Active Ageing, Tan Tock Seng Hospital. He is faculty advisor to National Healthcare Group Health Outcomes Medical Education Research (NHG-HOMER); Adjunct Associate Professor of Yong Loo Lin School of Medicine, NUS; council member, Chapter of Clinician Educators; Fellow of the American Geriatric Society; and Associate Fellow of the Association for Medical Education in Europe. He is also adjunct faculty of the Centre for Healthcare Innovation and a member of the Research Management Committee, Geriatric Education and Research Institute.

Awarded the outstanding alumni award 2016 from the Massachusetts General Hospital Institute of Health Professions, Boston, USA, his enthusiasm in his role as “Geriatrician Educator Researcher” is evidenced by his comprehensive track record of scholarly work, including over 100 peer-reviewed publications; editorial board member of the Journal of Nutrition, Health and Aging and guest associate editor for Frontiers in Medicine and Frontiers in Aging Neuroscience; reviewer for major national grants, international journals and conferences; and research and teaching awards in the fields of Geriatric Medicine and Health Professions Education. He is chair of the scientific committee for the Asia Pacific Geriatrics Conference in 2016, and co-chair of the local scientific committee for ADI 2020.

A/Prof Lim has completed fellowships in dementia and cognitive disorders at Washington University, St Louis, Successful Aging Programme at St Louis University, and Trans-disciplinary Frailty Research To Achieve Healthy Ageing at University of Adelaide. As principal investigator of the seminal GERI-LABS and GERI-LABS2 studies, he leads a multi-disciplinary team of researchers in conducting cutting-edge research in the areas of frailty and sarcopenia. His passion and dedication in raising regional interest and standards in the field of geriatric medicine, frailty and sarcopenia are evident in his involvement with the Asia Pacific Geriatrics Network; the Asian Working Group for Sarcopenia; and a co-author of the widely-cited Asia-Pacific Clinical Practice Guidelines for frailty.

In the area of dementia research, A/Prof Lim has been instrumental in demonstrating the salience of the multidimensional approach to caregiver burden. In particular, his seminal work on “worry about performance” caregiver burden has also been replicated in fields outside of dementia. His research in the area of caregiving is now focusing on the complementary and protective role of mastery against adverse caregiver outcomes. He is also the lead author of the highly cited Cochrane review on the role of omega-3 supplementation in prevention of dementia. His other areas of interest in the area of cognitive disorders include cognitive frailty, delirium, and mild cognitive impairment.

Dr Atri is the Senior Scientist in the Alzheimer’s Prevention Initiative at Banner Sun Health Research Institute. Dr Atri is an internationally renowned cognitive neurologist, clinician-researcher and educator in the fields of Alzheimer’s disease (AD) and Related Dementias (ADRD). His research utilises mathematical/statistical methods, biomarkers, and clinical trial/effectiveness methodologies to focus on early detection, risk reduction, and treatment and care of AD/ADRD. He boasts a BS Mathematics, MS Biomathematics and PhD Biomathematics, UCLA; concurrent with MD, UCSF, amongst many other qualifications.

Dr Atri advises and has led several large international investigational medicines/clinical trials programs for AD. He serves as co-chair of the Alzheimer’s Association U.S. national best clinical practices (AADx-CPG) workgroup on evaluation of cognitive behavioural syndromes, Alzheimer’s disease and ADRD. Dr Atri is also the Vice Chair of Alzheimer’s Disease International’s (ADI), Medical and Scientific Advisory Panel (MSAP).

Professor Kim is the director of the Korean National Institute of Dementia (KNID). He is also a professor of the department of Psychiatry, Seoul National University College of Medicine and the department of Brain and Cognitive Science, Seoul National University College of Natural Sciences. He is a geriatric psychiatrist and leading the Center for Dementia and Geriatric Cognitive Disorders in Seoul National University Bundang Hospital.

Professor Kim is the principal investigator of the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD) and an active member of the Cohort Studies of Memory in an International Consortium (COSMIC).

His major research interests are neuroimaging, neurophysiology and epidemiology of dementia and dementia policy.

The couple live in Australia and are retired Social Workers, who are actively involved in dementia advocacy both nationally and internationally. Both are on advisory committees for Dementia Australia (DA). Eileen is secretary for Dementia Alliance International (DAI), hosting their online weekly support group for Australian and New Zealand. Both Eileen and Dubhglas are cofounders of the Dementia Awareness Advocacy Team (DAAT).

RESERVE YOUR SEAT AT ADI'S FLAGSHIP CONFERENCE FOR 2020.